Clinical Trial Update: Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of JTT-705 in combination with atorvastatin 20 mg in patients with low HDL levels has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• JTT-705
• atorvastatin (atorvastatin)

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED